Pharmaceuticals in South Africa

Summary

Datamonitor's Pharmaceuticals in Brazil industry profile is an essential resource for top-level data and analysis covering the Brazil industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

• Contains an executive summary and data on value, volume and/or segmentation
• Provides textual analysis of the industry's recent performance and future prospects
• Incorporates in-depth five forces competitive environment analysis and scorecards
• Includes a five-year forecast of the industry
• The leading companies are profiled with supporting key financial metrics
• Supported by the key macroeconomic and demographic data affecting the market

Highlights

• Detailed information is included on market size, measured by value and/or volume
• Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
• Market shares are covered by manufacturer or brand

Why you should buy this report

• Spot future trends and developments
• Inform your business decisions
• Add weight to presentations and marketing materials
• Save time carrying out entry-level research

Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2007 annual average exchange rates.

The global figure comprises the Americas, Asia-Pacific and Europe.

For the purpose of this report the Americas comprises Brazil, Canada, Mexico, and the US.

Contents

• TABLE OF CONTENTS
• EXECUTIVE SUMMARY
• Chapter 1 Market Overview
  • 1.1 Market Definition
  • 1.2 Research Highlights
  • 1.3 Market Analysis
• Chapter 2 Market Value
• CHAPTER 3 Market Segmentation I
• CHAPTER 4 Market Segmentation II
• Chapter 5 Market Share
• Chapter 6 Five Forces Analysis
  • 6.1 Summary
  • 6.2 Buyer Power
  • 6.3 Supplier Power
  • 6.4 New Entrants
  • 6.5 Substitutes
  • 6.6 Rivalry
• Chapter 7 Leading Companies
  • 7.1 Novartis AG
  • 7.2 GlaxoSmithKline Plc
  • 7.3 EMS Sigma Pharma Group
  • 7.4 Pfizer Inc
• Chapter 8 Market Forecasts
  • 8.1 Market Value Forecast
• Chapter 9 Macroeconomic Indicators
• Chapter 1 Appendix
  • 1.1 Methodology
  • 1.2 Industry Associations
  • 1.3 Related Datamonitor Research
• LIST OF TABLES
  • Table 1: Brazil Pharmaceuticals Market Value: $ billion, 2004-2008
  • Table 2: Brazil Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
  • Table 3: Brazil Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
  • Table 4: Brazil Pharmaceuticals Market Share: % Share, by Value, 2008(e)
  • Table 5: Key Facts: Novartis AG
  • Table 6: Key Financials: Novartis AG
  • Table 7: Key Facts: GlaxoSmithKline Plc
  • Table 8: Key Financials: GlaxoSmithKline Plc
  • Table 9: Key Facts: EMS Sigma Pharma Group
  • Table 10: Key Facts: Pfizer Inc
  • Table 11: Key Financials: Pfizer Inc
  • Table 12: Brazil Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
  • Table 13: Brazil Size of Population (million) , 2004-2008
  • Table 14: Brazil GDP (Constant 2000 Prices, $ billion), 2004-2008
  • Table 15: Brazil Inflation, 2004-2008
  • Table 16: Brazil Exchange Rate, 2004-2008